MDxHealth SA Files 6-K Report with Press Release

Ticker: MDXH · Form: 6-K · Filed: Mar 12, 2024 · CIK: 1872529

Mdxhealth SA 6-K Filing Summary
FieldDetail
CompanyMdxhealth SA (MDXH)
Form Type6-K
Filed DateMar 12, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: 6-K, foreign-private-issuer, press-release

TL;DR

MDxHealth SA dropped a 6-K with a press release on March 12, 2024 - check Exhibit 99.1 for deets.

AI Summary

On March 12, 2024, MDxHealth SA announced the issuance of a press release, attached as Exhibit 99.1 to this Form 6-K filing. The press release details information relevant to the company's operations and financial status for the month of March 2024. The company is a foreign private issuer and files reports under Form 20-F.

Why It Matters

This filing provides investors with updated information directly from MDxHealth SA, offering insights into the company's recent activities and financial disclosures.

Risk Assessment

Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial events or material changes.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing by MDxHealth SA?

The primary purpose is to report information that MDxHealth SA has made or is required to make public in Belgium, file with or submit to the relevant stock exchange, or distribute to its security holders, specifically by attaching a press release as Exhibit 99.1.

When was the press release attached to this filing issued?

The press release was issued on March 12, 2024.

What is the Commission File Number for MDxHealth SA?

The Commission File Number for MDxHealth SA is 001-40996.

Does MDxHealth SA file annual reports under Form 20-F or Form 40-F?

MDxHealth SA files annual reports under cover of Form 20-F.

Where is MDxHealth SA's principal executive office located?

MDxHealth SA's principal executive office is located at CAP Business Center, Zone Industrielle des Hauts-Sarts, 4040 Herstal, Belgium.

Filing Stats: 272 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2024-03-12 17:01:37

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MDXHEALTH SA Date: March 12, 2024 By: /s/ Michael McGarrity Name: Michael McGarrity Title: Chief Executive Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing